# ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer

> **NCT02175017** · PHASE2 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 104 (actual)

## Conditions studied

- Advanced Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** ONO-4538
- **DRUG:** ONO-4538

## Key facts

- **NCT ID:** NCT02175017
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-11
- **Final completion:** 2021-02
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02175017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02175017, "ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02175017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*